NKG2Anull NK cells exhibit higher cytotoxicity and increased ADCC activity and the potential to kill tumor cells expressing HLA-E or HLA-G; however, the proliferative capacity of NKG2Anull NK cells may be poor in HLA-Enull tumor tissues because of strong inhibitory signals. The gene discussed is HLA-E; the disease is neoplasm.